These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 30287838)
1. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes. Saha SK; Jeong Y; Cho S; Cho SG Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838 [TBL] [Abstract][Full Text] [Related]
2. Oct4 pseudogenes are transcribed in cancers. Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer. Wezel F; Pearson J; Kirkwood LA; Southgate J Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063 [TBL] [Abstract][Full Text] [Related]
4. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines. Poursani EM; Mohammad Soltani B; Mowla SJ Cell J; 2016; 18(1):28-36. PubMed ID: 27054116 [TBL] [Abstract][Full Text] [Related]
5. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells. Xu G; Yang L; Zhang W; Wei X Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509 [TBL] [Abstract][Full Text] [Related]
6. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma. Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266 [TBL] [Abstract][Full Text] [Related]
7. A novel variant of Oct3/4 gene in mouse embryonic stem cells. Guo CL; Liu L; Jia YD; Zhao XY; Zhou Q; Wang L Stem Cell Res; 2012 Sep; 9(2):69-76. PubMed ID: 22683460 [TBL] [Abstract][Full Text] [Related]
8. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells. Asadi MH; Khalifeh K; Mowla SJ J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657 [TBL] [Abstract][Full Text] [Related]
9. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710 [TBL] [Abstract][Full Text] [Related]
10. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells. Poursani EM; Mehravar M; Soltani BM; Mowla SJ Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482 [TBL] [Abstract][Full Text] [Related]
11. Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells. Jez M; Ambady S; Kashpur O; Grella A; Malcuit C; Vilner L; Rozman P; Dominko T PLoS One; 2014; 9(2):e89546. PubMed ID: 24586860 [TBL] [Abstract][Full Text] [Related]
12. Characterization of novel alternative splicing variants of Oct4 gene expressed in mouse pluripotent stem cells. Liu X; Yu T; Sun Y; Wang H J Cell Physiol; 2018 Jul; 233(7):5468-5477. PubMed ID: 29266259 [TBL] [Abstract][Full Text] [Related]
13. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance. Gwak JM; Kim M; Kim HJ; Jang MH; Park SY Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735 [TBL] [Abstract][Full Text] [Related]
14. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712 [TBL] [Abstract][Full Text] [Related]
15. The novel function of OCT4B isoform-265 in genotoxic stress. Gao Y; Wei J; Han J; Wang X; Su G; Zhao Y; Chen B; Xiao Z; Cao J; Dai J Stem Cells; 2012 Apr; 30(4):665-72. PubMed ID: 22247013 [TBL] [Abstract][Full Text] [Related]
16. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4. Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994 [TBL] [Abstract][Full Text] [Related]
17. OCT4B modulates OCT4A expression as ceRNA in tumor cells. Li D; Yang ZK; Bu JY; Xu CY; Sun H; Tang JB; Lin P; Cheng W; Huang N; Cui RJ; Yu XG; Zheng XL Oncol Rep; 2015 May; 33(5):2622-30. PubMed ID: 25812694 [TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661 [TBL] [Abstract][Full Text] [Related]
19. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population. Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522 [TBL] [Abstract][Full Text] [Related]
20. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells. Choi SH; Kim JK; Jeon HY; Eun K; Kim H Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]